300 related articles for article (PubMed ID: 23966300)
21. Staphylococcus coagulase-positive skin inflammation associated with epidermal growth factor receptor-targeted therapy: an early and a late phase of papulopustular eruptions.
Amitay-Laish I; David M; Stemmer SM
Oncologist; 2010; 15(9):1002-8. PubMed ID: 20709888
[TBL] [Abstract][Full Text] [Related]
22. Epidermal ADAM17 maintains the skin barrier by regulating EGFR ligand-dependent terminal keratinocyte differentiation.
Franzke CW; Cobzaru C; Triantafyllopoulou A; Löffek S; Horiuchi K; Threadgill DW; Kurz T; van Rooijen N; Bruckner-Tuderman L; Blobel CP
J Exp Med; 2012 Jun; 209(6):1105-19. PubMed ID: 22565824
[TBL] [Abstract][Full Text] [Related]
23. Skin toxicities associated with epidermal growth factor receptor inhibitors.
Li T; Perez-Soler R
Target Oncol; 2009 Apr; 4(2):107-19. PubMed ID: 19452131
[TBL] [Abstract][Full Text] [Related]
24. Epidermal growth factor receptor inhibitors selectively inhibit the expressions of human β-defensins induced by Staphylococcus epidermidis.
Park K; Ommori R; Imoto K; Asada H
J Dermatol Sci; 2014 Aug; 75(2):94-9. PubMed ID: 24831548
[TBL] [Abstract][Full Text] [Related]
25. Skin toxicity caused by EGFR antagonists-an autoinflammatory condition triggered by deregulated IL-1 signaling?
Rodeck U
J Cell Physiol; 2009 Jan; 218(1):32-4. PubMed ID: 18781585
[TBL] [Abstract][Full Text] [Related]
26. Epidermal growth factor receptor tyrosine kinase inhibitors induce CCL2 and CCL5 via reduction in IL-1R2 in keratinocytes.
Yamaki M; Sugiura K; Muro Y; Shimoyama Y; Tomita Y
Exp Dermatol; 2010 Aug; 19(8):730-5. PubMed ID: 20590818
[TBL] [Abstract][Full Text] [Related]
27. The role of interleukin-1 in wound biology. Part II: In vivo and human translational studies.
Hu Y; Liang D; Li X; Liu HH; Zhang X; Zheng M; Dill D; Shi X; Qiao Y; Yeomans D; Carvalho B; Angst MS; Clark JD; Peltz G
Anesth Analg; 2010 Dec; 111(6):1534-42. PubMed ID: 20889944
[TBL] [Abstract][Full Text] [Related]
28. Markers in the epidermal growth factor receptor pathway and skin toxicity during erlotinib treatment.
Tan AR; Steinberg SM; Parr AL; Nguyen D; Yang SX
Ann Oncol; 2008 Jan; 19(1):185-90. PubMed ID: 17878175
[TBL] [Abstract][Full Text] [Related]
29. Hair follicle-derived IL-7 and IL-15 mediate skin-resident memory T cell homeostasis and lymphoma.
Adachi T; Kobayashi T; Sugihara E; Yamada T; Ikuta K; Pittaluga S; Saya H; Amagai M; Nagao K
Nat Med; 2015 Nov; 21(11):1272-9. PubMed ID: 26479922
[TBL] [Abstract][Full Text] [Related]
30. Managing dermatologic toxicities of epidermal growth factor receptor inhibitors.
Chou LS; Garey J; Oishi K; Kim E
Clin Lung Cancer; 2006 Dec; 8 Suppl 1():S15-22. PubMed ID: 17239286
[TBL] [Abstract][Full Text] [Related]
31. Hair eruption initiates and commensal skin microbiota aggravate adverse events of anti-EGFR therapy.
Klufa J; Bauer T; Hanson B; Herbold C; Starkl P; Lichtenberger B; Srutkova D; Schulz D; Vujic I; Mohr T; Rappersberger K; Bodenmiller B; Kozakova H; Knapp S; Loy A; Sibilia M
Sci Transl Med; 2019 Dec; 11(522):. PubMed ID: 31826981
[TBL] [Abstract][Full Text] [Related]
32. Requirement of MyD88 signaling in keratinocytes for Langerhans cell migration and initiation of atopic dermatitis-like symptoms in mice.
Didovic S; Opitz FV; Holzmann B; Förster I; Weighardt H
Eur J Immunol; 2016 Apr; 46(4):981-92. PubMed ID: 26694221
[TBL] [Abstract][Full Text] [Related]
33. Activation of the epidermal growth factor receptor in macrophages regulates cytokine production and experimental colitis.
Lu N; Wang L; Cao H; Liu L; Van Kaer L; Washington MK; Rosen MJ; Dubé PE; Wilson KT; Ren X; Hao X; Polk DB; Yan F
J Immunol; 2014 Feb; 192(3):1013-23. PubMed ID: 24391216
[TBL] [Abstract][Full Text] [Related]
34. Blockade of the EGF receptor induces a deranged chemokine expression in keratinocytes leading to enhanced skin inflammation.
Mascia F; Mariani V; Girolomoni G; Pastore S
Am J Pathol; 2003 Jul; 163(1):303-12. PubMed ID: 12819035
[TBL] [Abstract][Full Text] [Related]
35. [Dendritic epidermal T cells: sentinels of the skin].
Gieryńska M; Schollenberger A; Cespedes IS; Pawlak E
Postepy Hig Med Dosw (Online); 2009 Mar; 63():114-22. PubMed ID: 19373192
[TBL] [Abstract][Full Text] [Related]
36. Dysbiosis and Staphylococcus aureus Colonization Drives Inflammation in Atopic Dermatitis.
Kobayashi T; Glatz M; Horiuchi K; Kawasaki H; Akiyama H; Kaplan DH; Kong HH; Amagai M; Nagao K
Immunity; 2015 Apr; 42(4):756-66. PubMed ID: 25902485
[TBL] [Abstract][Full Text] [Related]
37. Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities.
Lacouture ME; Anadkat MJ; Bensadoun RJ; Bryce J; Chan A; Epstein JB; Eaby-Sandy B; Murphy BA;
Support Care Cancer; 2011 Aug; 19(8):1079-95. PubMed ID: 21630130
[TBL] [Abstract][Full Text] [Related]
38. A decrease in D-dimer concentration and an occurrence of skin rash as iatrogenic events and complementary predictors of survival in lung cancer patients treated with EGFR tyrosine kinase inhibitors.
Zaborowska-Szmit M; Kowalski DM; Piórek A; Krzakowski M; Szmit S
Pharmacol Rep; 2016 Dec; 68(6):1140-1148. PubMed ID: 27588390
[TBL] [Abstract][Full Text] [Related]
39. Rash as a surrogate marker for efficacy of epidermal growth factor receptor inhibitors in lung cancer.
Perez-Soler R
Clin Lung Cancer; 2006 Dec; 8 Suppl 1():S7-14. PubMed ID: 17239291
[TBL] [Abstract][Full Text] [Related]
40. Mast cells are dispensable in a genetic mouse model of chronic dermatitis.
Sulcova J; Meyer M; Guiducci E; Feyerabend TB; Rodewald HR; Werner S
Am J Pathol; 2015 Jun; 185(6):1575-87. PubMed ID: 25843682
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
